The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-((1H-pyrazol-3-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-5-(pyridin-2-yl)thiophene-2-sulfonamide ID: ALA1078492
PubChem CID: 45102707
Max Phase: Preclinical
Molecular Formula: C23H23N5O2S2
Molecular Weight: 465.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccn2)s1
Standard InChI: InChI=1S/C23H23N5O2S2/c29-32(30,23-7-6-22(31-23)21-3-1-2-11-24-21)27-19-5-4-17-9-13-28(14-10-18(17)15-19)16-20-8-12-25-26-20/h1-8,11-12,15,27H,9-10,13-14,16H2,(H,25,26)
Standard InChI Key: OSRBIQHRPHNLEN-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
12.8065 -22.7987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8052 -23.6233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5156 -24.0348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5137 -22.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1470 -23.1855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7246 -22.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8890 -22.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7863 -23.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9451 -24.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2347 -23.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2291 -22.7948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0929 -24.0334 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3818 -23.6212 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.7853 -22.9084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9634 -22.9084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6665 -24.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0413 -23.1559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5145 -23.9155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2656 -24.7715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0039 -25.2772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7130 -24.7309 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4127 -23.8879 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9968 -23.5423 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.3298 -24.0234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5810 -24.8062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4033 -24.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6165 -23.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6183 -22.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9059 -22.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1944 -22.7999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1996 -23.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9126 -24.0311 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
13 16 1 0
5 17 1 0
5 6 1 0
17 18 1 0
18 19 1 0
6 7 1 0
5 8 1 0
9 10 1 0
10 11 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 18 2 0
16 23 1 0
11 7 1 0
8 9 1 0
2 3 1 0
2 12 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 16 2 0
3 10 2 0
24 27 1 0
12 13 1 0
27 28 2 0
1 2 2 0
28 29 1 0
13 14 2 0
29 30 2 0
11 4 2 0
30 31 1 0
13 15 2 0
31 32 2 0
32 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 465.60Molecular Weight (Monoisotopic): 465.1293AlogP: 3.93#Rotatable Bonds: 6Polar Surface Area: 90.98Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.29CX Basic pKa: 7.91CX LogP: 2.39CX LogD: 2.47Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -2.12
References 1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.. (2009) The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor., 19 (22): [PMID:19804969 ] [10.1016/j.bmcl.2009.09.027 ]